RSA press coverage8 Aug 2014 07:47
Sell RSA as turnaround labours:
RSA Insurance’s first set of results, following some major balance sheet surgery under Stephen Hester, was an opportunity to show shareholders the promise of a brighter future. RSA, formerly known as Royal and Sun Alliance, first hit problems in November last year.
A black hole was discovered in the Irish division’s accounts, which required a near-doubling of reserves from £70 million to £130 million.
The gap in the Irish arm’s insurance loss reserves was compounded by a £220 million fraud. RSA launched a £748 million discounted rights issue in March, the Baltic and Polish divisions were sold in April to raise a further £300 million, and the share price was consolidated five-for-one in May.
This offset a strong performance in Scandinavia. Looking at the company as a whole, the amount of insurance it is writing is falling, with net written premiums down 9% to £3.9 billion. And the core insurance business is only just breaking even, with a profit from underwriting of £2 million, down from £188 million in the same period last year.
The problem for RSA is that with record low bond yields, investment returns are also falling, down from £192 million to £166 million. Once you add in head office, interest and restructuring costs, the company reported first-half, pretax profits of £69 million, down from £250 million at the same stage last year.
Questor picked RSA as a very high risk buy last year (92½p, December 16) on the basis that the core business would attract buyers and it would resolve its problems. Questor thinks this is as good a time as any to bail out of this speculative tip, and downgrades to a sell.
RSA Insurance at 430½p-13.4p. Questor says “Sell”